Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress

Liu, Yajun; Li, Chenyao; Liu, Hongwei; Tan, Shutao

doi:10.1007/s12272-024-01494-1

Arch. Pharm. Res.

2024

DOI: 10.1007/s12272-024-01494-1

|View full text |Cite

Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress

Yajun Liu,

Chenyao Li,

Hongwei Liu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 168 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Architecting lymphoma fusion: PROMETHEE-II guided optimization of combination therapeutic synergy

Ansar,

Arya,

Soni

et al. 2024

Int. j. inf. tecnol.

View full text Add to dashboard Cite

Architecting lymphoma fusion: PROMETHEE-II guided optimization of combination therapeutic synergy

Ansar,

Arya,

Soni

et al. 2024

Int. j. inf. tecnol.

View full text Add to dashboard Cite

Innovations and Emerging Trends in Prostate Cancer Management: A Literature Review

Ibraheem,

Abdelglil,

Wanees

et al. 2024

Cureus

View full text Add to dashboard Cite

Prostate cancer (PC) is considered the second most diagnosed cancer in men worldwide. It remains a leading cause of cancer-related death. Recently, many modalities have been discovered and used in the diagnosis and management of PC, with the incorporation of many treatment options such as hormonal therapy, chemotherapy, targeted therapies, immunotherapy, and precision medicine. Robotics and artificial intelligence (AI) have further modified the diagnosis and management of PCs, improving the diagnosis accuracy and disease progression. This comprehensive review offers an in-depth exploration of the historical modalities of treatments, an evaluation of current therapeutic techniques, a discussion of the use of robotic surgery and AI, and an examination of ongoing clinical trials and emerging procedures. Additionally, this review also covers the challenges. By inspecting these aspects, the review may provide valuable information regarding future research and clinical practice directions in PC treatment, contributing to a thorough understanding of the complex and emerging context of PC management.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress

Cited by 2 publications

References 168 publications

Architecting lymphoma fusion: PROMETHEE-II guided optimization of combination therapeutic synergy

Architecting lymphoma fusion: PROMETHEE-II guided optimization of combination therapeutic synergy

Innovations and Emerging Trends in Prostate Cancer Management: A Literature Review

Contact Info

Product

Resources

About